Al-Kafaji, G. Et Al. 2018. Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification. ONCOLOGY LETTERS , vol.16, no.1 , 1357-1365.

Al-Kafaji, G., Said, H. M., Alam, M. A., & Al Naieb, Z. T., (2018). Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification. ONCOLOGY LETTERS , vol.16, no.1, 1357-1365.

Al-Kafaji, Ghada Et Al. "Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification," ONCOLOGY LETTERS , vol.16, no.1, 1357-1365, 2018

Al-Kafaji, Ghada Et Al. "Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification." ONCOLOGY LETTERS , vol.16, no.1, pp.1357-1365, 2018

Al-Kafaji, G. Et Al. (2018) . "Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification." ONCOLOGY LETTERS , vol.16, no.1, pp.1357-1365.

@article{article, author={Ghada Al-Kafaji Et Al. }, title={Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification}, journal={ONCOLOGY LETTERS}, year=2018, pages={1357-1365} }